DUBLIN--(BUSINESS WIRE)--The "Global Graft vs Host Disease (GVHD) Treatment Market 2017-2021" report has been added to Research and Markets' offering.
The global graft vs host disease (GVHD) treatment market to grow at a CAGR of 7.15% during the period 2017-2021.
Global Graft vs Host Disease (GVHD) Treatment Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report also includes a discussion of the Key vendors operating in this market. To calculate the market size, the report considers sales of branded, generic, and off-label drugs.
According to the report, one driver in the market is increased prevalence of cancer. Globally, cancer is one of the life-threating diseases. As per National Institutes of Health (NIH), it is the second largest cause of death globally.
One trend in the market is inorganic growth strategies. The inorganic growth strategies are expected to contribute the growth of GVHD treatment market as the market is completely based on off-label usage. These inorganic growth strategies include global merger and acquisition, partnerships and regional acquisition.
Key vendors
- Bristol-Myers Squibb
- Novartis
- Pfizer
- F. Hoffmann-La Roche
Other prominent vendors
- Abbott
- AbbVie
- Allergan
- Anterogen
- Astellas Pharma
- Athersys
- Baxter
- Caladrius
- Cellular Biomedicine Group
- Cipla
- Eisai
- Eli Lilly
- GlaxoSmithKline
- Glenmark
- Helsinn Healthcare
- Heron Therapeutics
- Incyte Corporation
- IPCA Laboratories
- Kadmon Holdings
- Lupin
- Osiris Therapeutics
- RedHill
- Sanofi
- Shire
- Sun Pharmaceutical Industries
- Takeda Pharmaceutical
-
ViaCyte
Key Topics Covered:
- Executive Summary
- Scope Of The Report
- Research Methodology
- Introduction
- Disease Overview
- Market Overview
- Pipeline Landscape
- Market Segmentation By Disease Type
- Geographical Segmentation
- Decision Framework
- Drivers And Challenges
- Market Trends
- Vendor Landscape
- Key Vendor Analysis
- Appendix
For more information about this report visit https://www.researchandmarkets.com/research/mwfdxc/global_graft_vs
